tradingkey.logo
搜索

BNB Plus Ord Shs

BNBX
添加自选
0.163USD
0.0000.00%
收盘 07-13 16:00(美东)
836.63K总市值
0.00市盈率 TTM

关于 BNB Plus Ord Shs 公司

Applied DNA Sciences, Inc. is a biotechnology company. The Company is engaged in developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The Company operates through three segments: Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. Therapeutic DNA Production Services segment operations consist of the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and, the development and sale of a proprietary RNAP for use in the production of messenger RNA (mRNA) therapeutics. MDx Testing Service segment operations consist of performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. DNA Tagging and Security Products and Services segment operations consist of the manufacture and detection of DNA for industrial supply chains and security services.

BNB Plus Ord Shs 简介

公司代码- -
公司名称- -
上市日期- -
CEO- -
员工数量- -
证券类型- -
年结日- -
公司地址- -
城市- -
上市交易所- -
国家- -
邮编- -
电话- -
网址- -
公司代码- -
上市日期- -
CEO- -

BNB Plus Ord Shs公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Joseph D. Ceccoli
Mr. Joseph D. Ceccoli
Independent Director
Independent Director
22.51K
+0.00%
Mr. Robert B. (Bob) Catell
Mr. Robert B. (Bob) Catell
Independent Director
Independent Director
22.51K
--
Dr. Yacov A. Shamash, Ph.D.
Dr. Yacov A. Shamash, Ph.D.
Independent Director
Independent Director
22.51K
-0.01%
Ms. Judith Murrah
Ms. Judith Murrah
Director
Director
18.69K
-302.82%
Ms. Judith Murrah
Ms. Judith Murrah
Director
Director
18.69K
-302.82%
Ms. Judith Murrah
Ms. Judith Murrah
Director
Director
18.69K
-302.82%
Mr. Clay Shorrock, J.D.
Mr. Clay Shorrock, J.D.
President, Chief Executive Officer
President, Chief Executive Officer
12.62K
--
Mr. Clay Shorrock, J.D.
Mr. Clay Shorrock, J.D.
President, Chief Executive Officer
President, Chief Executive Officer
12.62K
--
Mr. Clay Shorrock, J.D.
Mr. Clay Shorrock, J.D.
President, Chief Executive Officer
President, Chief Executive Officer
12.62K
--
Ms. Beth M. Jantzen
Ms. Beth M. Jantzen
Chief Financial Officer
Chief Financial Officer
10.21K
-0.01%
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Joseph D. Ceccoli
Mr. Joseph D. Ceccoli
Independent Director
Independent Director
22.51K
+0.00%
Mr. Robert B. (Bob) Catell
Mr. Robert B. (Bob) Catell
Independent Director
Independent Director
22.51K
--
Dr. Yacov A. Shamash, Ph.D.
Dr. Yacov A. Shamash, Ph.D.
Independent Director
Independent Director
22.51K
-0.01%
Ms. Judith Murrah
Ms. Judith Murrah
Director
Director
18.69K
-302.82%
Ms. Judith Murrah
Ms. Judith Murrah
Director
Director
18.69K
-302.82%
Ms. Judith Murrah
Ms. Judith Murrah
Director
Director
18.69K
-302.82%

常见问题

BNB Plus Ord Shs的前五大股东是谁?

BNB Plus Ord Shs 的前五大股东如下:Dr. Yacov A. Shamash, Ph.D.

哪个业务部门对BNB Plus Ord Shs的收入贡献最大?

在2026Q4,Product and authentication services - Large scale DNA production业务部门对BNB Plus Ord Shs的收入贡献最大,创收423.01K,占总收入的74.82%。
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有